blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2273999

EP2273999 - COMPOSITION COMPRISING POLYSACCHARIDE EXTRACTED FROM PANAX GINSENG PREVENTING AND TREATING LIVER DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.01.2018
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  17.02.2017
FormerGrant of patent is intended
Status updated on  14.02.2017
FormerExamination is in progress
Status updated on  06.02.2017
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Korea Institute of Radiological & Medical Sciences
215-4 Gongneung-dong
Nowon-gu, Seoul 139-240 / KR
[2011/03]
Inventor(s)01 / YUN, Yeon-Sook
110-807 Mido Apt.
Daechi-dong
Gangnam-gu
Seoul 135-280 / KR
02 / SONG, Jie-Young
201-1801 GangchonMaeul Apt.
783 Madu 2-dong
IlsanDong-gu
Goyang-si Gyeonggi-do 410-716 / KR
03 / JUNG, In-Sung
5-31 (2/1) Hyehwa-dong
Jongno-gu
Seoul 110-530 / KR
 [2017/12]
Former [2011/03]01 / YUN, Yeon-Sook
110-807 Mido Apt. Daechi-dong Gangnam-gu
Seoul 135-280 / KR
02 / SONG, Jie-Young
201-1801 GangchonMaeul Apt. 783 Madu 2-dong IlsanDong-gu
Goyang-si Gyeonggi-do 410-716 / KR
03 / JUNG, In-Sung
5-31 (2/1) Hyehwa-dong Jongno-gu
Seoul 110-530 / KR
Representative(s)Leonard, Thomas Charles, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2017/12]Leonard, Thomas Charles, et al
Kilburn & Strode LLP
20 Red Lion Street
London WC1R 4PJ / GB
Former [2011/03]Leonard, Thomas Charles, et al
Kilburn & Strode LLP 20 Red Lion Street
GB-London WC1R 4PJ / GB
Application number, filing date09729322.907.04.2009
[2011/03]
WO2009KR01789
Priority number, dateKR2008003238607.04.2008         Original published format: KR 20080032386
[2011/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009125964
Date:15.10.2009
Language:EN
[2009/42]
Type: A2 Application without search report 
No.:EP2273999
Date:19.01.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 15.10.2009 takes the place of the publication of the European patent application.
[2011/03]
Type: B1 Patent specification 
No.:EP2273999
Date:22.03.2017
Language:EN
[2017/12]
Search report(s)International search report - published on:KR30.12.2009
(Supplementary) European search report - dispatched on:EP24.06.2013
ClassificationIPC:A61K36/258
[2011/03]
CPC:
A61K36/258 (EP,KR,US); A61K31/715 (KR); A61P1/16 (EP);
A61P35/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/12]
Former [2011/03]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZUSAMMENSETZUNG MIT AUS PANAX GINSENG EXTRAHIERTEM POLYSACCHARID ZUR PRÄVENTION UND BEHANDLUNG VON LEBERERKRANKUNGEN[2011/03]
English:COMPOSITION COMPRISING POLYSACCHARIDE EXTRACTED FROM PANAX GINSENG PREVENTING AND TREATING LIVER DISEASES[2011/03]
French:COMPOSITION COMPRENANT UN POLYSACCHARIDE EXTRAIT DE PANAX GINSENG DESTINÉE À LA PRÉVENTION ET AU TRAITEMENT DE MALADIES HÉPATIQUES[2011/03]
Entry into regional phase06.10.2010National basic fee paid 
06.10.2010Search fee paid 
06.10.2010Designation fee(s) paid 
06.10.2010Examination fee paid 
Examination procedure06.10.2010Examination requested  [2011/03]
21.01.2014Amendment by applicant (claims and/or description)
20.04.2016Despatch of a communication from the examining division (Time limit: M02)
29.06.2016Reply to a communication from the examining division
10.10.2016Communication of intention to grant the patent
01.02.2017Fee for grant paid
01.02.2017Fee for publishing/printing paid
03.02.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.02.2017Information about intention to grant a patent
14.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.04.2016
Opposition(s)02.01.2018No opposition filed within time limit [2018/09]
Fees paidRenewal fee
12.04.2011Renewal fee patent year 03
28.03.2012Renewal fee patent year 04
12.04.2013Renewal fee patent year 05
25.03.2014Renewal fee patent year 06
10.04.2015Renewal fee patent year 07
11.04.2016Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.04.2009
AT22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
MK22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
TR22.03.2017
IE07.04.2017
LU07.04.2017
MT07.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
[2020/15]
Former [2019/51]HU07.04.2009
AT22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
MK22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
IE07.04.2017
LU07.04.2017
MT07.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2019/46]HU07.04.2009
AT22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
IE07.04.2017
LU07.04.2017
MT07.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2019/31]HU07.04.2009
AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
IE07.04.2017
LU07.04.2017
MT07.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/43]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
IE07.04.2017
LU07.04.2017
MT07.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/23]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
IE07.04.2017
LU07.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/13]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
LU07.04.2017
CH30.04.2017
LI30.04.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/09]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/07]AT22.03.2017
CZ22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
FR22.05.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/06]AT22.03.2017
CZ22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2017/51]AT22.03.2017
CZ22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2017/50]AT22.03.2017
CZ22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
Former [2017/49]AT22.03.2017
CZ22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
Former [2017/48]CZ22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
SE22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
Former [2017/41]FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
SE22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
Documents cited:Search[Y]US2003190378  (KIM DONG-HYUN [KR], et al) [Y] 4-8 * page 1, paragraph 6 * * page 10, paragraphs 146, 153 *;
 [Y]WO9502968  (NIWANO SHICHIRO [JP]) [Y] 7,8 * abstract *;
 [IY]  - SONG JLE-YOUNG ET AL, "Effects of polysaccharide ginsan from Panax ginseng on liver function", ARCHIVES OF PHARMACAL RESEARCH, NATL. FISHERIES UNIVERSITY, PUSAN, KR, (20040501), vol. 27, no. 5, doi:10.1007/BF02980127, ISSN 0253-6269, pages 531 - 538, XP008095595 [I] 1 * the whole document * [Y] 2-8

DOI:   http://dx.doi.org/10.1007/BF02980127
 [Y]  - LEE Y-S ET AL, "ACTIVATION OF MULTIPLE EFFECTOR PATHWAYS OF IMMUNE SYSTEM BY THE ANTINEOPLASTIC IMMUNOSTIMULATOR ACIDIC POLYSACCHARIDE GINSAN ISOLATED FROM PANAX GINSENG", ANTICANCER RESEARCH, INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH, GR, (19970101), vol. 17, no. 1A, ISSN 0250-7005, pages 323 - 331, XP001117999 [Y] 1-7 * abstract * * page 324, column left, paragraph 3 * * page 324, column right, paragraph 1 *
 [Y]  - YEON SOOK YUN1 ET AL, "Inhibition of Autochthonous Tumor by Ethanol Insoluble Fraction from Panax ginseng as an Immunomodulator", PLANTA MEDICA, THIEME VERLAG, DE, (19931201), vol. 59, no. 6, doi:10.1055/S-2006-959752, ISSN 0032-0943, pages 521 - 524, XP009168746 [Y] 3 * Fractionation of Panax gingseng; page 521, column right *

DOI:   http://dx.doi.org/10.1055/s-2006-959752
 [Y]  - ASSINEWE V A ET AL, "Extractable polysaccharides of Panax quinquefolius L. (North American ginseng) root stimulate TNFalpha production by alveolar macrophages", MEDICINAL & AROMATIC PLANTS ABSTRACTS, SCIENTIFIC PUBLISHERS, SCIENTIFIC PUBLISHERS, NEW DELHI - INDIA, (20030801), vol. 25, no. 4, ISSN 0250-4367, XP018012694 [Y] 3 * abstract * * page 399, column left, lines 15-20, paragraph 5 * * page 399, column right, lines 1-7, paragraph 1 *
 [Y]  - LIM, T-S. ET AL, "Immunomodulating activities of polysaccharides isolted from Panax gingseng", JOURNAL OF MEDICAL FOOD, (20040707), vol. 7, no. 1, pages 1 - 6, XP002698657 [Y] 1,3 * abstract * * page 2, column left, paragraph 6 * * page 2, column right, paragraph 1 *

DOI:   http://dx.doi.org/10.1089/109662004322984626
 [Y]  - Jie-Young Song ET AL, "Radioprotective effects of ginsan, an immunomodulator.", Radiat Res, (20030101), pages 768 - 774, URL: http://www.ginsan.com.hk/documents/ginsan12.pdf, (20130415), XP055059649 [Y] 1 * abstract *

DOI:   http://dx.doi.org/10.1667/0033-7587(2003)159[0768:REOGAI]2.0.CO;2
 [Y]  - BATALLER R ET AL, "Liver fibrosis", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, (20050201), vol. 115, no. 2, doi:10.1172/JCI200524282, ISSN 0021-9738, pages 209 - 218, XP002450194 [Y] 6 * page 216, column left, lines 1-4 *

DOI:   http://dx.doi.org/10.1172/JCI200524282
International search[Y]KR100190756B  (CHOONGWAE PHARM CO [KR])
 [X]  - ASSINEWE V. A. ET AL., "Extractable polysaccharides of Panax quinquefolius L. (North American ginseng) root stimulate TNFa production by alveolar macrophages", PHYTOMEDICINE, (2002), vol. 9, no. 5, pages 398 - 404, XP004957107

DOI:   http://dx.doi.org/10.1078/09447110260571625
by applicant   - Remington's Pharmaceutical Science, MACK PUBLISHING COMPANY
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.